Pilar Alarma-Estrany Selected Research

5- methoxycarbonylamino- N- acetyltryptamine

3/2009	Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
12/2007	Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pilar Alarma-Estrany Research Topics

Disease

4	Glaucoma 09/2011 - 12/2007
3	Ocular Hypertension (Glaucoma, Suspect) 05/2009 - 12/2007
1	Wounds and Injuries (Trauma) 01/2015

Drug/Important Bio-Agent (IBA)

2	5- methoxycarbonylamino- N- acetyltryptamineIBA 03/2009 - 12/2007
1	Heptanol (1 Heptanol)IBA 01/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2015
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2011
1	NucleotidesIBA 05/2009
1	ParasympathomimeticsIBA 05/2009
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2009
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2009
1	Proteins (Proteins, Gene)FDA Link 05/2009
1	Small Interfering RNA (siRNA)IBA 05/2009
1	MelatoninIBA 12/2007

Therapy/Procedure

1	Slit Lamp 01/2015